檢索結果 - Peyrade, Frederic

Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer 由 Barrière, Jérôme, Re, Daniel, Peyrade, Frédéric, Carles, Michel

獲取全文 獲取全文 獲取全文

Hodgkin’s Lymphoma in Older Patients: an Orphan Disease? 由 Thyss, Antoine, Saada, Esma, Gastaud, Lauris, Peyrade, Frédéric, Re, Daniel

獲取全文 獲取全文 獲取全文

Impact of cetuximab conventional dosing on cetuximab-induced magnesium concentration under haemodialysis in head and neck cancer 由 Thariat, Juliette, Launay-Vacher, Vincent, Italiano, Antoine, Santini, José, Peyrade, Frederic

獲取全文 獲取全文 獲取全文

Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation 由 Peyrade, Frederic, Re, Daniel, Ginet, Clemence, Gastaud, Lauris, Allegra, Maryline, Ballotti, Robert, Thyss, Antoine, Zenz, Thorsten, Auberger, Patrick, Robert, Guillaume

獲取全文 獲取全文 獲取全文

Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib 由 Bailleux, Caroline, Robert, Guillaume, Ginet, Clémence, Re, Daniel, Thyss, Antoine, Sudaka, Isabelle, Peyrottes, Isabelle, Hofman, Paul, Auberger, Patrick, Peyrade, Frederic

獲取全文 獲取全文

Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphom... 由 Tardy, Magalie P., Gastaud, Lauris, Ojeda-Uribe, Mario, Boscagli, Annick, Caruso, Salvatore, Skaf, Richard, Gutnecht, Jean, Thyss, Antoine, Peyrade, Frédéric

獲取全文 獲取全文 獲取全文

Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics 由 Refae, Sadal, Gal, Jocelyn, Brest, Patrick, Giacchero, Damien, Borchiellini, Delphine, Ebran, Nathalie, Peyrade, Frederic, Guigay, Joël, Milano, Gérard, Saada-Bouzid, Esma

獲取全文 獲取全文 獲取全文

Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics 由 Refae, Sadal, Gal, Jocelyn, Brest, Patrick, Giacchero, Damien, Borchiellini, Delphine, Ebran, Nathalie, Peyrade, Frederic, Guigay, Joël, Milano, Gérard, Saada-Bouzid, Esma

獲取全文 獲取全文 獲取全文

Interleukin-10 Gene Polymorphisms are Associated With Freedom From Treatment Failure for Patients With Hodgkin Lymphoma 由 Schoof, Nils, Franklin, Jeremy, Fürst, Robert, Zander, Thomas, von Bonin, Frederike, Peyrade, Frederic, Trümper, Lorenz, Diehl, Volker, Engert, Andreas, Kube, Dieter, Re, Daniel

獲取全文 獲取全文 獲取全文

Observational, prospective, phase 4 study in patients with first‐line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum‐b... 由 Guigay, Joël, Chamorey, Emmanuel, Lefebvre, Gautier, Rotarski, Maciej, Wagner, Jean‐Philippe, Blot, Emmanuel, Alfonsi, Marc, Seronde, Audrey, Schulten, Jeltje, Peyrade, Frédéric, Le Tourneau, Christophe

獲取全文 獲取全文 獲取全文

Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway 由 Robert, Guillaume, Jullian, Valérie, Jacquel, Arnaud, Ginet, Clémence, Dufies, Maeva, Torino, Stephanie, Pottier, Anaïs, Peyrade, Frederic, Tartare-Deckert, Sophie, Bourdy, Geneviève, Deharo, Eric, Auberger, Patrick

獲取全文 獲取全文

Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03 由 Fayette, Jerome, Guigay, Joel, Tourneau, Christophe Le, Degardin, Marian, Peyrade, Frederic, Neidhardt, Eve-Marie, Sablin, Marie-Paule, Even, Caroline, Orlandini, Florence, Juzyna, Béata, Bellera, Carine

獲取全文 獲取全文 獲取全文

DPD status and fluoropyrimidines-based treatment: high activity matters too 由 Chamorey, Emmanuel, Francois, Eric, Etienne, Marie-Christine, Ferrero, Jean-Marc, Peyrade, Frederic, Barranger, Emmanuel, Bozec, Alexandre, Largillier, Rémy, Cassuto, Ophelie, Viotti, Julien, Schiappa, Renaud, Milano, Gérard

獲取全文 獲取全文 獲取全文

Nous devons respecter le schéma vaccinal anti-SARS-CoV-2 sans décalage chez les patients atteints de cancer sous traitement 由 Barrière, Jérôme, Audigier-Valette, Clarisse, Borchiellini, Delphine, Hoch, Benjamin, Castelnau, Olivier, Francois, Eric, Gastaud, Lauris, Skaf, Richard, Berdah, Jean-François, Marie, Wislez, Lescaut, Willy, Peyrade, Frédéric, Cluzeau, Thomas, Cassuto, Ophélie, Carles, Michel

獲取全文 獲取全文 獲取全文

Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study 由 Wang, Michael, Ramchandren, Radhakrishnan, Chen, Robert, Karlin, Lionel, Chong, Geoffrey, Jurczak, Wojciech, Wu, Ka Lung, Bishton, Mark, Collins, Graham P., Eliadis, Paul, Peyrade, Frédéric, Lee, Yihua, Eckert, Karl, Neuenburg, Jutta K., Tam, Constantine S.

獲取全文 獲取全文 獲取全文

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME 由 Chevalier, Thomas, Daste, Amaury, Saada‐Bouzid, Esmaa, Loundou, Anderson, Peyraud, Florent, Lambert, Tiphaine, Le Tourneau, Christophe, Peyrade, Frédéric, Dupuis, Charlotte, Alfonsi, Marc, Fayette, Jérôme, Reure, Juliette, Huguet, Florence, Fakhry, Nicolas, Toullec, Clémence, Salas, Sébastien

獲取全文 獲取全文 獲取全文

Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study 由 Montaudié, Henri, Viotti, Julien, Combemale, Patrick, Dutriaux, Caroline, Dupin, Nicolas, Robert, Caroline, Mortier, Laurent, Kaphan, Régis, Duval-Modeste, Anne-Bénédicte, Dalle, Stéphane, De Quatrebarbes, Julie, Stefan, Andrea, Brunet-Possenti, Florence, Kogay, Maria, Picard-Gauci, Alexandra, Poissonnet, Gilles, Peyrade, Frédéric

獲取全文 獲取全文 獲取全文

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies 由 Cabannes‐Hamy, Aurélie, Peyrade, Frederic, Jardin, Fabrice, Emile, Jean‐François, Delwail, Vincent, Mounier, Nicolas, Haioun, Corinne, Perrot, Aurore, Fitoussi, Olivier, Lara, Diane, Delarue, Richard, André, Marc, Offner, Fritz, Ghesquières, Hervé, Pascal, Laurent, Soussain, Carole, Lazarovici, Julien, Schiano, Jean‐Marc, Gaulard, Philippe, Tilly, Hervé, Thieblemont, Catherine

獲取全文 獲取全文 獲取全文

FCGR3A/2A polymorphisms and Diffuse Large B-cell Lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1,134 patients from two prospective cohorts 由 Ghesquières, Hervé, Larrabee, Beth R., Haioun, Corinne, Link, Brian K., Verney, Aurélie, Slager, Susan L., Ketterer, Nicolas, Ansell, Stephen M., Delarue, Richard, Maurer, Matthew J., Fitoussi, Olivier, Habermann, Thomas M., Peyrade, Fréderic, Dogan, Ahmet, Molina, Thierry J., Novak, Anne J., Tilly, Hervé, Cerhan, James R., Salles, Gilles

獲取全文 獲取全文 獲取全文

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy 由 Maurer, Matthew J., Ghesquières, Hervé, Jais, Jean-Philippe, Witzig, Thomas E., Haioun, Corinne, Thompson, Carrie A., Delarue, Richard, Micallef, Ivana N., Peyrade, Frédéric, Macon, William R., Jo Molina, Thierry, Ketterer, Nicolas, Syrbu, Sergei I., Fitoussi, Olivier, Kurtin, Paul J., Allmer, Cristine, Nicolas-Virelizier, Emmanuelle, Slager, Susan L., Habermann, Thomas M., Link, Brian K., Salles, Gilles, Tilly, Hervé, Cerhan, James R.

獲取全文 獲取全文 獲取全文